These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 1361742)

  • 1. Large diurnal variation in CD4 cell count and T-cell function among drug users: implications for clinical practice and epidemiological studies.
    Mientjes GH; van Ameijden EJ; Roos MT; de Leeuw NA; van den Hoek JA; Coutinho RA; Miedema FF
    AIDS; 1992 Nov; 6(11):1269-72. PubMed ID: 1361742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variation of the CD4 count among drug users.
    Mientjes GH; van Ameijden EJ; van den Hoek JA; Roos MT; Coutinho RA
    J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):205-6. PubMed ID: 7905526
    [No Abstract]   [Full Text] [Related]  

  • 3. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important.
    Malone JL; Simms TE; Gray GC; Wagner KF; Burge JR; Burke DS
    J Acquir Immune Defic Syndr (1988); 1990; 3(2):144-51. PubMed ID: 1967309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis in HIV-positive and HIV-negative drug users in Amsterdam].
    Keizer ST; Langendam MW; van Deutekom H; Coutinho RA; van Ameijden FJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):184-9. PubMed ID: 9557024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users.
    Mientjes GH; Miedema F; van Ameijden EJ; van den Hoek AA; Schellekens PT; Roos MT; Coutinho RA
    AIDS; 1991 Jan; 5(1):35-41. PubMed ID: 1829366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for pneumonia in HIV infected and non-infected drug users.
    Mientjes GH; Spijkerman IJ; van Ameijden EJ; van den Hoek JA; Coutinho RA
    J Infect; 1996 May; 32(3):181-6. PubMed ID: 8793706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid manual method for CD4+ T-cell quantitation for use in developing countries.
    Landay A; Ho JL; Hom D; Russell T; Zwerner R; Minuty JG; Kataaha P; Mmiro F; Jackson B
    AIDS; 1993 Dec; 7(12):1565-8. PubMed ID: 7904449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
    Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
    AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users.
    Lyles CM; Margolick JB; Astemborski J; Graham NM; Anthony JC; Hoover DR; Vlahov D
    AIDS; 1997 Aug; 11(10):1255-62. PubMed ID: 9256944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.
    Keet IP; Krol A; Koot M; Roos MT; de Wolf F; Miedema F; Coutinho RA
    AIDS; 1994 Nov; 8(11):1577-83. PubMed ID: 7848594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
    Margolick JB; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson KE
    JAMA; 1992 Mar; 267(12):1631-6. PubMed ID: 1347321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers for disease progression in intravenous drug users infected with HIV-1.
    Zangerle R; Fuchs D; Reibnegger G; Fritsch P; Wachter H
    AIDS; 1991 Aug; 5(8):985-91. PubMed ID: 1685652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up.
    Phillips AN; Sabin CA; Elford J; Bofill M; Lee CA; Janossy G
    AIDS; 1993 Jul; 7(7):975-80. PubMed ID: 8102854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men.
    Mientjes GH; van Ameijden EJ; Mulder JW; van den Hoek JA; Coutinho RA; von dem Borne AE
    Br J Haematol; 1992 Nov; 82(3):615-9. PubMed ID: 1486043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.
    Spijkerman IJ; Prins M; Goudsmit J; Veugelers PJ; Coutinho RA; Miedema F; de Wolf F
    AIDS; 1997 Sep; 11(11):1383-8. PubMed ID: 9302449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.
    Landay A; Benning L; Bremer J; Weiser B; Burger H; Nowicki M; Kovacs A
    J Infect Dis; 2003 Jul; 188(2):209-18. PubMed ID: 12854075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count).
    Hoepelman AI; van Buren M; van den Broek J; Borleffs JC
    AIDS; 1992 Feb; 6(2):179-84. PubMed ID: 1348416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection.
    van Asten L; Danisman F; Otto SA; Borghans JA; Hazenberg MD; Coutinho RA; Prins M; Miedema F
    AIDS; 2004 Sep; 18(14):1885-93. PubMed ID: 15353974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.